Finding Answers Through Collaboration
Published on in CHOP News
Unique endocrinology-neurology collaboration seeks to understand the variation in seizure activity in patients with hyperinsulinism/hyperammonemia.
Division of Endocrinology and Diabetes News and Updates
1 - 10 of 54
Treatment Developed by CHOP Researchers Prevents Hypoglycemia in Children with Hyperinsulinism
Published on in CHOP News
CHOP researchers have shown that a targeted treatment they developed is effective at controlling blood sugar in patients with hyperinsulinism.
Volunteer Spotlight: Rachel Walega
Published on in CHOP News
Eighteen months ago, the Office of Endocrinology and Diabetes welcomed Rachel Walega to their team as a Clinical Research Project Manager. There, Rachel works on projects in Cystic Fibrosis related diabetes, Down syndrome and bone fragility.
CHOP Researchers Define a 3-Tiered Molecular Classification of Pediatric Differentiated Thyroid Cancer, where Fusion Oncogenes Predict the Most Invasive Behavior
Published on in CHOP News
CHOP researchers have defined a 3-tiered molecular classification of pediatric differentiated thyroid cancer, where fusion oncogenes predict the most invasive behavior.
Meet Diva De León-Crutchlow, MD, MSCE
Published on in CHOP News
Diva De León-Crutchlow, MD, MSCE, assumed the role of Director of the Congenital Hyperinsulinism Center in 2013 and was named Chief of the Division of Endocrinology and Diabetes in 2018.
Coping with a Dual Diagnosis
Published on in HI Hope
Parents are usually blindsided when they find out that their child has congenital hyperinsulinism (HI), a rare genetic disorder that depresses blood sugar to dangerously low levels.
Rare Pair: HI and Kabuki Syndrome
Published on in HI Hope
Low blood sugar is one of the symptoms of Kabuki syndrome, a genetic disorder that affects multiple systems in the body but can be tricky to diagnose.
Researchers Show Novel Device Improves Blood Sugar Control in Hyperinsulinism Patients Whose Pancreas Has Been Removed
Published on in CHOP News
A pilot study at CHOP is the first to demonstrate the effectiveness of the bihormonal bionic pancreas in hyperinsulinism patients.
Youth-Onset Type 2 Diabetes Leads to Serious Complications by Early Adulthood
Published on in CHOP News
The landmark TODAY2 study found that those diagnosed with type 2 diabetes during childhood and adolescence have a high risk of developing serious health complications by early adulthood.
CHOP Adrenal and Puberty Center Named Center of Excellence
Published on in CHOP News
CARES Foundation has named CHOP as a Center for Excellence in Congenital Adrenal Hyperplasia.